TSS
AMED

Two Sigma Securities’s Amedisys AMED Stock Holding History

Two Sigma Securities’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,440
Closed -$226K – 1473
2025
Q1 		$226K Buy
+2,440
New +$225K 0.03% 788
2024
Q3 		– Sell
-2,314
Closed -$212K – 2805
2024
Q2 		$212K Buy
+2,314
New +$215K ﹤0.01% 2310
2023
Q1 		– Sell
-3,209
Closed -$268K – 2612
2022
Q4 		$268K Sell
3,209
-2,000
-38% -$180K 0.01% 1645
2022
Q3 		$504K Buy
5,209
+1,664
+47% +$198K 0.02% 1099
2022
Q2 		$373K Buy
3,545
+1,667
+89% +$213K 0.01% 1125
2022
Q1 		$324K Buy
+1,878
New +$281K 0.01% 1342
2020
Q3 		– Sell
-1,113
Closed -$221K – 1280
2020
Q2 		$221K Buy
+1,113
New +$208K 0.01% 1078

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Two Sigma Securities's AMED Position: Q2 2025 in Review

Two Sigma Securities sold out of Amedisys (AMED) in Q2 2025, closing a stake of 2,440 shares — an estimated $226K sold.

Two Sigma Securities first reported a position in AMED in Q2 2020 and held it in 7 quarters. The position peaked at $504K in Q3 2022. 319 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Two Sigma Securities reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,440 Amedisys shares in Q2 2025, an estimated $226K.
  • Two Sigma Securities first reported a position in Amedisys in Q2 2020 and held it in 7 quarters.
  • Two Sigma Securities's Amedisys position peaked at $504K in Q3 2022.
  • 319 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Two Sigma Securities's 13F filing for Q2 2025, filed 14 Aug 2025.